- Home
- Resources
- Regulatory information
MiFID II
Data templates
Artemis supports the European ESG Template (EET), European PRIIPs Template (EPT) and European MiFID Template (EMT), which are the data exchanges endorsed by EFAMA to facilitate the dissemination of this information.
The purpose of this webpage is to make these templates available to distributors and clients to ensure that they are able to meet their regulatory obligations.
Data files are provided in a CSV format, and are disseminated on a quarterly basis.
Alternatively, you can get the EMT from a wide range of third party data platforms, including FEFundinfo & Morningstar. Please contact your preferred distributor directly.
European ESG Template (EET)
The EET provides data on the sustainability features of our products.
European PRIIPs Template (EPT)
The EPT provides data required for the Packaged Retail and Insurance-based Investment Products (PRIIPS).
European MiFID Template (EMT)
The EMT provides information on the ‘ex ante’ costs and charges and target markets associated with Artemis’ investment products.
Please note: all of our MiFID II reporting has been prepared using information we reasonably consider to be accurate. Artemis Investment Management LLP makes no warranty that the information contained in any of our MiFID II regulatory reporting is appropriate or sufficient for any particular use or in any particular territory.
Product governance
MiFID II requires investment firms which manufacture products to maintain, operate and review a process for the approval of each product and significant changes of existing products before they are marketed or distributed to clients.
Target market assessment
Artemis’ product approval approach specifies the intended target market of end-clients during the design stage and ensures all relevant risks to the identified target market are assessed.
Investment firms have a duty to ensure that their distributors are distributing their products correctly, to the appropriate target market for each fund. This involves a two-way information-sharing between advisers and product providers. The target market for each product is set out in the European MiFID Template (EMT).
Complexity of products
Only ‘non-complex’ products are permitted to be made available to private investors without any advice or suitability checks.
In accordance with Article 25(4)(a) of the MiFID II Directive, all Artemis UK and Luxembourg domiciled UCITS funds are classified as non-complex.
We have applied the tests set out in Article 57 of MiFID II to our non-UCITS funds and these also meet all the necessary criteria to be classed as non-complex.
Product reviews
All products undergo an annual review to ensure that funds: (i) are continuing to meet client needs; (ii) are performing as expected; (iii) are still appropriate for the identified end-clients, and that, overall, the distribution strategy remains compatible with the target market. The periodic reviews are complementary to existing day-to-day oversight and monitoring responsibilities across the business, and are designed to provide a holistic overview of a fund.
Find out more about Artemis' product governance framework
The full Artemis governance framework is available upon request.
Order execution policy
In accordance with the FCA Handbook Rules and Guidance, when executing orders, Artemis is required to take sufficient steps to consistently obtain the best possible result for its clients taking into account relevant execution factors and any specific client instructions. This document outlines adherence to the set of requirements outlined in COBS of the FCA Handbook in relation to best-execution policy and execution arrangements.
PRIIPs KIDs
Where relevant, PRIIPS KIDs are available in our literature library.
